Success Metrics

Clinical Success Rate

100.0%

Based on 4 completed trials

Completion Rate

100%(4/4)

Active Trials

2(33%)

Results Posted

50%(2 trials)

Phase Distribution

Ph phase_3

17%

Ph not_applicable

83%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution6 total trials

Phase 3Large-scale testing

1(16.7%)

N/ANon-phased studies

5(83.3%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(4)

Detailed Status

Completed4

Recruiting2

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 3

Trials by Phase

Phase 31 (16.7%)

N/A5 (83.3%)

Trials by Status

completed467%

recruiting233%

Recent Activity

2 active trials

Showing 5 of 6

recruitingnot_applicable

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

NCT04956549

recruitingnot_applicable

Clinical Trials (6)

Showing 6 of 6 trials

NCT04956549Not Applicable

Reducing African American's Alzheimer's Risk Through Exercise-Mild Cognitive Impairment (RAATE-MCI)

Recruiting

NCT03890861Not Applicable

Reducing African Americans' Alzheimer's Disease Risk Through Exercise (RAATE)"

Recruiting

NCT03573583Not Applicable

Time Course Adaptations Using Deuterated Creatine (D3Cr) Method

Completed

NCT03474302Not Applicable

Program for African American Cognition & Exercise

Completed

NCT01072500Phase 3

The LIFE Study - Lifestyle Interventions and Independence for Elders

Completed

NCT01094509Not Applicable

Activities for Cognitive Enhancement of Seniors

Completed

All 6 trials loaded

Drug Details

Intervention Type: BEHAVIORAL
Total Trials: 6